Pfizer sells midphase inflammatory drugs to mystery startup, exiting race against Bristol Myers
Pfizer is getting out of TYK2. Having studied its lead inhibitor in a raft of
Pfizer is getting out of TYK2. Having studied its lead inhibitor in a raft of
The ongoing Aryan Khan drugs case has become the principal fodder for primetime news channels
Good day. Biotechnology startup Expansion Therapeutics Inc. has collected $80 million to hunt for oral
Exclusive: Bruised star Katie Price could face jail for a 6am ‘drink and drugs’ crash